Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test
Sponsor: Fudan University
Summary
This is a multicenter, cross-sectional study. It is based on fecal methylation site detection, H. pylori susceptibility testing of fecal samples, and a combination of the two, compared with the "gold standard" imaging tests, CT, gastroscopy and/or pathology, for gastric cancer, benign diseases such as gastritis, and health check-ups.
Official title: Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes for the Early Diagnosis and Screening of Gastric Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
9654
Start Date
2025-12-01
Completion Date
2026-06-30
Last Updated
2025-06-24
Healthy Volunteers
Yes
Conditions
Interventions
fecal methylation site-based testing and fecal Helicobacter pylori gastric cancer susceptibility gene-based testing
To establish an early diagnostic test system for gastric cancer based on the methylation site detection technology in feces, with or without the combination of Helicobacter pylori gastric cancer susceptibility gene detection, and then to evaluate the clinical diagnostic value of this test system.